Gary Charles Robb, Chief Business Officer: Corcept Therapeutics CORT Sell · Filed 25/05/22

Trade details

Type: Insider sale
Amount: $172,862.15
Shares · price: 2,279 sh · $75.85 a share
Held after: 16,586 sh
Stock: Corcept Therapeutics CORT
Person: Gary Charles RobbChief Business Officer
Trade date: 25/05/20
Filed: 25/05/22
Days to filing: 2 days

Sold 12.1% of holdings

Share of holding sold: 12.1%

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/20~25/06/19

Gary Charles Robb's recent trades

Gary Charles RobbChief Business Officer
Planned saleCorcept Therapeutics
Planned sale
Corcept Therapeutics
CORT
$1.2M
10,000 sh
$1.2M
Filed 08/17
Traded 08/17
Gary Charles RobbChief Business Officer
SellCorcept Therapeutics
Sell
Corcept Therapeutics
CORT
$165.8K
2,326 sh
$165.8K
Filed 25/08/26
Traded 25/08/22
Gary Charles RobbChief Business Officer
Planned saleCorcept Therapeutics
Planned sale
Corcept Therapeutics
CORT
$165.8K
2,326 sh
$165.8K
Filed 25/08/22
Traded 25/08/22
Gary Charles RobbChief Business Officer
SellCorcept Therapeutics
Sell
Corcept Therapeutics
CORT
$225.4K
3,185 sh
$225.4K
Filed 25/06/18
Traded 25/06/16
Gary Charles RobbChief Business Officer
Planned saleCorcept Therapeutics
Planned sale
Corcept Therapeutics
CORT
$225.4K
3,185 sh
$225.4K
Filed 25/06/16
Traded 25/06/16